Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

APLAUD study evaluates SB-214857 in patients with coronary artery and cerebrovascular disease

Nov. 9, 1998

YM-75466 possesses significant advantages over warfarin as oral anticoagulant

Nov. 6, 1998

Potential new antithrombotic agent profiled, structure revealed

Nov. 4, 1998

Hungarian research team presents new antithrombotic thioglycosides

Nov. 2, 1998

Japan Tobacco obtains rights to Terumo antiplatelet agent

Oct. 30, 1998

Ajinomoto prepares extensive series with anticoagulant efficacy

Oct. 30, 1998

Ibex to resume testing of heparin-reversing agent

Oct. 30, 1998

Melagatran in different vehicles compared in rat model of thrombosis

Oct. 28, 1998

Advisory committee decides against recommending approval for new anticoagulant

Oct. 27, 1998

RPR presents clinical findings with gpIIb/IIIa antagonist; product dropped due to dosing problems

Oct. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...